90.00
—
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Acer Medical
Its shares trade on Taipei Exchange under the ticker 6857.TWO. It has been listed since 27 October 2021. In the fiscal year to 31 December 2025, it reported revenue of TWD 60.1m and a net loss of TWD 29.7m. At that date it held total assets of TWD 207.2m and shareholders' equity of TWD 164.9m.
Acer Medical, Inc. provides technology solutions based on artificial intelligence (AI) and big data to medical facilities and other medical industries. The company is headquartered in Taipei, New Taipei. The company went IPO on 2021-10-27. The firm's main business is the development and provision of artificial intelligence medical diagnostic software and telemedicine solutions. The Artificial Intelligence Medical Diagnostic Software business helps medical professionals to make accurate and rapid diagnoses through Artificial Intelligence Diagnostic Software. The Telemedicine Solutions business offers two main services: telepresence clinics, which provide telemedicine consultations with physicians in people's homes and medical facilities for chronic or non-emergency conditions, and telecare sites or specialist consultations, which provide telemedicine consultations with physicians or nurse practitioners and specialists at health clinics. The firm operates products in domestic and overseas markets, and its sales markets are divided into domestic and foreign markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 27 Oct 2021
- Website
- acer-medical.com ↗
Leadership
Pay as last reported
- Mr. Jia-En LienChairman of the Board, since 2023
- Kaicheng XuGeneral Manager
- Mingyuan ChenHead of Finance & Accounting
- Mr. Chun-Shen ChenDirector
- Shouren GuoIndependent Director
- Xusong GuoIndependent Director
- Menghan WuIndependent Director
- Mr. Wenyue ZhanIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Acer Medical Inc's AI medical diagnostic software enhances diagnostic accuracy and speed in medical facilities.
- Telepresence clinics provide home-based telemedicine consultations for chronic and non-emergency conditions.
- Telecare sites offer specialist consultations through telemedicine at health clinics nationwide.
Weaknesses
- Acer Medical Inc's domestic market sales are limited to Taiwan's healthcare sector.
- The company's telemedicine solutions face competition from established domestic healthcare providers.
- Overseas market penetration remains limited due to regulatory challenges in foreign countries.
Opportunities
- Expanding AI medical diagnostic software usage in Taiwan's growing healthcare infrastructure.
- Increasing telemedicine adoption in overseas markets like Southeast Asia and Europe.
- Growing demand for telecare sites in aging populations across Asia-Pacific regions.
Threats
- Regulatory changes in Taiwan's healthcare sector may impact AI diagnostic software deployment.
- Competition from global telemedicine platforms entering the Asian market.
- Economic downturns in key overseas markets could reduce telemedicine service demand.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.